Pharma Co. Impel's Ch. 11 Liquidation Plan Approved

By Ben Zigterman · April 1, 2024, 5:07 PM EDT

Migraine-drug maker Impel Pharmaceuticals received confirmation of its Chapter 11 liquidation plan on Monday after selling its assets and making changes to the plan's exculpation provisions in response to a U.S....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

IPI Legacy Liquidation Co.

Case Number

Court

Texas Northern

Nature of Suit

Date Filed

December 19, 2023

Recent Articles By Ben

October 15, 2024
Fla. Medical Co. Hits Ch. 11 With Plans For Quick $45M Sale
August 13, 2024
Pioneer Health Ch. 11 Plan With Future Sale Gets OK
June 08, 2024
From Delaware To Georgia: Why LaVie Is Taking Ch. 11 South
May 07, 2024
Pear Therapeutics Ch. 11 Liquidation Plan Confirmed
April 10, 2024
Bankrupt Breast Implant Co. Gets OK For $50.5M Asset Sales
April 04, 2024
Acorda Gets Interim OK For $60M DIP With $40M Rollup
March 27, 2024
US Trustee Opposes New Official Committee In Talc Ch. 11
February 05, 2024
Zymergen Ch. 11 Plan Confirmed After Investor Objection
February 01, 2024
Bankrupt Pharma Co. Impel Gets OK For $17.5M Sale
January 29, 2024
US Trustee, Rite Aid Negotiate Revised Mediation Order